Eton Pharmaceuticals, Inc. (ETON)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Sean E. Brynjelsen | President, CEO & Director | 939.42k | -- | 1972 |
| Mr. James R. Gruber CPA | CFO, Treasurer & Secretary | 554.44k | -- | 1972 |
| Mr. David C. Krempa | Chief Business Officer | 547.86k | -- | 1989 |
| Danka Radosavljevic | Senior Vice President of Quality & Operations | -- | -- | -- |
| Mr. Scott Grossenbach | Vice President of Sales Operations | -- | -- | -- |
| Mr. Kevin Guthrie | Executive VP of Commercial Operations | -- | -- | -- |
Eton Pharmaceuticals, Inc.
- Sector:?
- Healthcare
- Industry:? Drug Manufacturers - Specialty & Generic
- Full Time Employees:?
- 30
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Corporate Governance
Upcoming Events
August 8, 2024 at 8:01 PM UTC
Eton Pharmaceuticals, Inc. Earnings Date